Cargando…
Chemical Space Exploration with Active Learning and Alchemical Free Energies
[Image: see text] Drug discovery can be thought of as a search for a needle in a haystack: searching through a large chemical space for the most active compounds. Computational techniques can narrow the search space for experimental follow up, but even they become unaffordable when evaluating large...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558370/ https://www.ncbi.nlm.nih.gov/pubmed/36148968 http://dx.doi.org/10.1021/acs.jctc.2c00752 |
_version_ | 1784807429639241728 |
---|---|
author | Khalak, Yuriy Tresadern, Gary Hahn, David F. de Groot, Bert L. Gapsys, Vytautas |
author_facet | Khalak, Yuriy Tresadern, Gary Hahn, David F. de Groot, Bert L. Gapsys, Vytautas |
author_sort | Khalak, Yuriy |
collection | PubMed |
description | [Image: see text] Drug discovery can be thought of as a search for a needle in a haystack: searching through a large chemical space for the most active compounds. Computational techniques can narrow the search space for experimental follow up, but even they become unaffordable when evaluating large numbers of molecules. Therefore, machine learning (ML) strategies are being developed as computationally cheaper complementary techniques for navigating and triaging large chemical libraries. Here, we explore how an active learning protocol can be combined with first-principles based alchemical free energy calculations to identify high affinity phosphodiesterase 2 (PDE2) inhibitors. We first calibrate the procedure using a set of experimentally characterized PDE2 binders. The optimized protocol is then used prospectively on a large chemical library to navigate toward potent inhibitors. In the active learning cycle, at every iteration a small fraction of compounds is probed by alchemical calculations and the obtained affinities are used to train ML models. With successive rounds, high affinity binders are identified by explicitly evaluating only a small subset of compounds in a large chemical library, thus providing an efficient protocol that robustly identifies a large fraction of true positives. |
format | Online Article Text |
id | pubmed-9558370 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-95583702022-10-14 Chemical Space Exploration with Active Learning and Alchemical Free Energies Khalak, Yuriy Tresadern, Gary Hahn, David F. de Groot, Bert L. Gapsys, Vytautas J Chem Theory Comput [Image: see text] Drug discovery can be thought of as a search for a needle in a haystack: searching through a large chemical space for the most active compounds. Computational techniques can narrow the search space for experimental follow up, but even they become unaffordable when evaluating large numbers of molecules. Therefore, machine learning (ML) strategies are being developed as computationally cheaper complementary techniques for navigating and triaging large chemical libraries. Here, we explore how an active learning protocol can be combined with first-principles based alchemical free energy calculations to identify high affinity phosphodiesterase 2 (PDE2) inhibitors. We first calibrate the procedure using a set of experimentally characterized PDE2 binders. The optimized protocol is then used prospectively on a large chemical library to navigate toward potent inhibitors. In the active learning cycle, at every iteration a small fraction of compounds is probed by alchemical calculations and the obtained affinities are used to train ML models. With successive rounds, high affinity binders are identified by explicitly evaluating only a small subset of compounds in a large chemical library, thus providing an efficient protocol that robustly identifies a large fraction of true positives. American Chemical Society 2022-09-23 2022-10-11 /pmc/articles/PMC9558370/ /pubmed/36148968 http://dx.doi.org/10.1021/acs.jctc.2c00752 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Khalak, Yuriy Tresadern, Gary Hahn, David F. de Groot, Bert L. Gapsys, Vytautas Chemical Space Exploration with Active Learning and Alchemical Free Energies |
title | Chemical Space
Exploration with Active Learning and
Alchemical Free Energies |
title_full | Chemical Space
Exploration with Active Learning and
Alchemical Free Energies |
title_fullStr | Chemical Space
Exploration with Active Learning and
Alchemical Free Energies |
title_full_unstemmed | Chemical Space
Exploration with Active Learning and
Alchemical Free Energies |
title_short | Chemical Space
Exploration with Active Learning and
Alchemical Free Energies |
title_sort | chemical space
exploration with active learning and
alchemical free energies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558370/ https://www.ncbi.nlm.nih.gov/pubmed/36148968 http://dx.doi.org/10.1021/acs.jctc.2c00752 |
work_keys_str_mv | AT khalakyuriy chemicalspaceexplorationwithactivelearningandalchemicalfreeenergies AT tresaderngary chemicalspaceexplorationwithactivelearningandalchemicalfreeenergies AT hahndavidf chemicalspaceexplorationwithactivelearningandalchemicalfreeenergies AT degrootbertl chemicalspaceexplorationwithactivelearningandalchemicalfreeenergies AT gapsysvytautas chemicalspaceexplorationwithactivelearningandalchemicalfreeenergies |